Outcomes of early oseltamivir treatment for hospitalized adult patients with community-acquired influenza pneumonia.

ABSTRACT: Early initiation of oseltamivir within 48 h to 5 days from illness onset has been associated with improved survival among patients with community-acquired influenza pneumonia. Delay of hospitalization limits early treatment and the survival of patients. To date, the effects of early oseltamivir initiation within 24 hours from admission on patient mortality has remained unknown. This retrospective study reviewed and analyzed the clinical and non-clinical outcomes of 143 patients, with community-acquired influenza pneumonia, who received oseltamivir within 24 h (group A) and after 24 h (group B) from admission. Among the patients, 82 (57.3%) received oseltamivir within 24 h while 61 (42.7%) received oseltamivir after 24 h. The median time from symptom onset to admission for group A and group

SUBMITTER: Kositpantawong N 

PROVIDER: S-EPMC8673668 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature